Research ArticleCARDIAC SIDE EFFECTS

Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase

See allHide authors and affiliations

Science Translational Medicine  10 Dec 2014:
Vol. 6, Issue 266, pp. 266ra170
DOI: 10.1126/scitranslmed.3010189

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article